Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $86.67.
Several analysts have weighed in on ACHC shares. Barclays cut their price objective on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. Royal Bank of Canada restated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft increased their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. Finally, KeyCorp assumed coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company.
Read Our Latest Stock Report on Acadia Healthcare
Institutional Trading of Acadia Healthcare
Acadia Healthcare Stock Performance
Shares of ACHC stock opened at $56.96 on Friday. The firm has a market capitalization of $5.28 billion, a price-to-earnings ratio of -406.86, a PEG ratio of 1.57 and a beta of 1.29. The stock has a fifty day moving average of $71.64 and a 200 day moving average of $69.88. Acadia Healthcare has a 52 week low of $53.22 and a 52 week high of $87.77. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $796.00 million during the quarter, compared to analyst estimates of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.92 EPS. As a group, research analysts expect that Acadia Healthcare will post 3.51 earnings per share for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- What is a SEC Filing?
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- AMD Gains Momentum With AI: Can It Beat Expectations?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.